Discover 1,280 paid clinical trials in Scottsdale, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,280
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
for
Asthma
Location: Chandler AZ, Henderson NV, Newport Beach CA,
Sponsor: Pfizer
Sex: All
Age: 18 - 70
Code: NCT06977581
Phase2, Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
for
Alzheimer's Disease
Location: Chandler AZ, Las Vegas NV, Orange CA, Garden Grove CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 55 - 70+
Code: NCT07011745
Phase3, Recruiting
A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
for
Hepatic Impairment
Location: Chandler AZ, Rialto CA, San Antonio TX, Miami Lakes FL
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07546760
Phase1, Recruiting
Product Surveillance Registry
for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Phoenix AZ, Chandler AZ, Chula Vista CA, San Diego CA,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT01524276
Recruiting
Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis
for
Liver Fibrosis, Hepatic Cirrhosis
Location: Chandler AZ, Tucson AZ, Las Vegas NV, Yukon OK,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07610837
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
for
Non-alcoholic Fatty Liver Disease
Location: Chandler AZ, Tucson AZ, Las Vegas NV, San Diego CA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07221227
Phase3, Recruiting
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
for
Contraception
Location: Chandler AZ, Salt Lake City UT, Sacramento CA,
Sponsor: Femasys Inc.
Sex: Female
Age: 21 - 50
Code: NCT05977751
Recruiting
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
for
Weight Management
Location: Chandler AZ, Lynwood CA, Arvada CO, Sacramento CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07667803
Phase3, Recruiting
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
for
Urothelial Carcinoma
Location: Gilbert AZ, San Diego CA, San Marcos CA, Fontana CA,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT04879329
Phase2, Recruiting
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
for
Excessive Sleepiness, Shift-work Disorder
Location: Chandler AZ, Henderson NV, Santa Ana CA, Anaheim CA,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06568367
Phase3, Recruiting
A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass
for
Ovarian Neoplasms
Location: Chandler AZ, Las Vegas NV, Lewisville TX, Mesquite TX,
Sponsor: Cleo Diagnostics Ltd
Sex: Female
Age: 18+
Code: NCT06566716
Recruiting
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
for
SLE, SLE (Systemic Lupus)
Location: Avondale AZ, Tucson AZ, Salt Lake City UT, Plano TX,
Sponsor: Cullinan Therapeutics Inc.
Sex: All
Age: 18 - 70
Code: NCT06613360
Phase1, Recruiting
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
for
Growth Hormone Deficiency
Location: Phoenix AZ, Las Vegas NV, Orange CA, El Paso TX,
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
for
Sickle Cell Disease
Location: Phoenix AZ, Fresno CA, Houston TX, Shreveport LA,
Sponsor: Sanofi
Sex: All
Age: 10 - 65
Code: NCT06975865
Phase3, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations